கார்ட்டர் கூல்ட் பார்க்லேஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கார்ட்டர் கூல்ட் பார்க்லேஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கார்ட்டர் கூல்ட் பார்க்லேஸ் Today - Breaking & Trending Today

Pfizer (PFE) Q2 2021 Earnings Call Transcript


Operator
Good day, everyone, and welcome to Pfizer s second-quarter 2021 earnings conference call. Today s call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo, senior vice president and chief investment relations officer.
Please go ahead, sir.
Senior Vice President and Chief Investment Relations Officer
Thank you, Sylvia. Good morning. It s my pleasure to be welcoming you to Pfizer s second-quarter earnings call for the first time as the head of investor relations at Pfizer. I m joined today by Dr.
Albert Bourla, our chairman and CEO; Frank D Amelio, our CFO; Mikael Dolsten, president of worldwide research and development and medical; Angela Hwang, group president, Pfizer Biopharmaceuticals Group; John Young, our chief business officer; and Doug Lankler, general counsel. We ll begin the call with remarks by Albert, followed by a pipeline update from Mikael, and Frank will then give you his thoughts on the numbers and our ....

United States , Boston University , United Kingdom , Frank Damelio , Daniel Busby , Andrew Baum , Albert Bourla , Kerry Holford Berenberg , Chris Stevo , Carter Gould , Angela Hwang , Doug Lankler , Andrew Baum Citi , Kerry Holford , Geoff Meacham , Carter Gould Barclays , America Merrill Lynch , Matthew Harrison Morgan Stanley , Mikael Dolsten , Chris Schott , Matthew Harrison , Geoffrey Porges , John Young , Ronny Gal , Morgan Stanley , Boston Medical Center ,

Reata Pharmaceuticals, Inc. (RETA) Q1 2021 Earnings Call Transcript


Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Reata Pharmaceuticals First Quarter 2021 Financial Results and Update on Development Programs Conference Call. An audio recording of today s webcast will be available shortly after the call today on Reata s website at reatapharma.com in the Investors section. Before the company proceeds with its remarks, please note the forward-looking statements disclosure in the company s press release. The company will be making forward-looking statements on today s call. There are many factors that could cause results to differ from expectations, including those noted in the company s SEC filings. On today s conference call, non-GAAP financial measures will be used to help investors understand the business performance. ....

United States , Yigal Nochomovitz Citigroup , Nick Rubino , Maury Raycroft , Manmeets Soni , Colin Meyer , Annabel Samimy , Carter Gould , Nick Rubino Stifel , Maury Raycroft Jefferies , Yigal Nochomovitz , Manmeet Soni , Carter Gould Barclays , Drug Administration , Advisory Committee , Research And Development , Reata Pharmaceuticals Inc , European Union , Development Programs Conference Call , Reata Pharmaceuticals , Reata Pharmaceutical First Quarter , Development Programs Conference , Chief Executive Officer , Warren Huff , Chief Research , Development Officer ,